These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38873935)

  • 1. Correction to "Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression".
    Aging Cell; 2024 Jul; 23(7):e14248. PubMed ID: 38873935
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression.
    Xu Q; Long Q; Zhu D; Fu D; Zhang B; Han L; Qian M; Guo J; Xu J; Cao L; Chin YE; Coppé JP; Lam EW; Campisi J; Sun Y
    Aging Cell; 2019 Dec; 18(6):e13027. PubMed ID: 31493351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis.
    Raimondo S; Saieva L; Vicario E; Pucci M; Toscani D; Manno M; Raccosta S; Giuliani N; Alessandro R
    J Hematol Oncol; 2019 Jan; 12(1):2. PubMed ID: 30621731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases.
    Salminen A
    J Mol Med (Berl); 2024 Jun; 102(6):733-750. PubMed ID: 38600305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor stroma-derived factors skew monocyte to dendritic cell differentiation toward a suppressive CD14
    Spary LK; Salimu J; Webber JP; Clayton A; Mason MD; Tabi Z
    Oncoimmunology; 2014 Oct; 3(9):e955331. PubMed ID: 25941611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Programmed Death-Ligand 1 by Human Colonic CD90
    Beswick EJ; Grim C; Singh A; Aguirre JE; Tafoya M; Qiu S; Rogler G; McKee R; Samedi V; Ma TY; Reyes VE; Powell DW; Pinchuk IV
    Front Immunol; 2018; 9():1125. PubMed ID: 29910803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphiregulin Regulates Melanocytic Senescence.
    Pommer M; Kuphal S; Bosserhoff AK
    Cells; 2021 Feb; 10(2):. PubMed ID: 33562468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
    Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S
    Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research advances of myeloid-derived suppressor cells mediated by programmed death-1/programmed death-ligand 1 pathway in sepsis-induced immunosuppression].
    Xu Y; Zang X; Chen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Mar; 36(3):332-336. PubMed ID: 38538366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senescent cells re-engineered to express soluble programmed death receptor-1 for inhibiting programmed death receptor-1/programmed death ligand-1 as a vaccination approach against breast cancer.
    Chen Z; Hu K; Feng L; Su R; Lai N; Yang Z; Kang S
    Cancer Sci; 2018 Jun; 109(6):1753-1763. PubMed ID: 29675979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells.
    Oliveras-Ferraros C; Cufí S; Queralt B; Vazquez-Martin A; Martin-Castillo B; de Llorens R; Bosch-Barrera J; Brunet J; Menendez JA
    Br J Cancer; 2012 Apr; 106(8):1406-14. PubMed ID: 22491422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-induced Rab11a-exosomes induce amphiregulin-mediated cetuximab resistance in colorectal cancer.
    Mason JD; Marks E; Fan SJ; McCormick K; Wilson C; Harris AL; Hamdy FC; Cunningham C; Goberdhan DCI
    J Extracell Vesicles; 2024 Jun; 13(6):e12465. PubMed ID: 38887984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
    Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE
    Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
    Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M
    Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Response to Immunotherapy Targeting Programmed Cell Death Receptor 1/Programmed Cell Death Ligand 1 in Patients With Treatment-Resistant Microsatellite Stable Colorectal Cancer With and Without Liver Metastases.
    Wang C; Sandhu J; Ouyang C; Ye J; Lee PP; Fakih M
    JAMA Netw Open; 2021 Aug; 4(8):e2118416. PubMed ID: 34369992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed Cell Death 1 Ligand 1 and Programmed Cell Death 1 Ligand 2 Are Expressed in Conjunctival Invasive Squamous Cell Carcinoma: Therapeutic Implications.
    Wolkow N; Jakobiec FA; Afrogheh AH; Eagle RC; Pai SI; Faquin WC
    Am J Ophthalmol; 2019 Apr; 200():226-241. PubMed ID: 30633894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression.
    Gao J; Ulekleiv CH; Halstensen TS
    J Exp Clin Cancer Res; 2016 Sep; 35(1):151. PubMed ID: 27669890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over expression of amphiregulin promoted malignant progression in gastric cancer.
    Jiang J; Zhao W; Tang Q; Wang B; Li X; Feng Z
    Pathol Res Pract; 2019 Oct; 215(10):152576. PubMed ID: 31466817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphiregulin increases migration and proliferation of epithelial ovarian cancer cells by inducing its own expression via PI3-kinase signaling.
    Bolitho C; Moscova M; Baxter RC; Marsh DJ
    Mol Cell Endocrinol; 2021 Aug; 533():111338. PubMed ID: 34062166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.